RecruitingNCT00353483

Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells


Sponsor

Washington University School of Medicine

Enrollment

300 participants

Start Date

Sep 14, 2005

Study Type

OBSERVATIONAL

Conditions

Summary

The main purpose of this study is to compare genetic markers present on tumor cells before and after chemotherapy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study examines how chemotherapy or hormone therapy given before or after breast cancer surgery changes the biology of breast tissue, aiming to understand which treatments work best and why. **You may be eligible if...** - You have been diagnosed with breast cancer and are scheduled to receive chemotherapy or hormone therapy before or after surgery - You are willing to have additional tissue samples collected during your scheduled surgery - You are 18 years of age or older **You may NOT be eligible if...** - You are not receiving systemic therapy (chemotherapy or hormonal treatment) as part of your breast cancer care - You have already completed all planned treatments - You have a bleeding disorder or other condition that makes tissue sampling unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPeripheral blood draw
PROCEDUREBreast tissue collection
PROCEDUREBone marrow biopsy

Locations(1)

Washington University School of Medicine

St Louis, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00353483


Related Trials